Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06311578
Title A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Johnson & Johnson Enterprise Innovation Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.